Salagen and Convulsion - a phase IV clinical study of FDA data

Summary:

Convulsion is reported as a side effect among people who take Salagen (pilocarpine hydrochloride), especially for people who are female, 60+ old, also take Synthroid, and have Breast cancer.

The phase IV clinical study analyzes which people have Convulsion when taking Salagen. It is created by eHealthMe based on reports of 1,907 people who have side effects when taking Salagen from the FDA, and is updated regularly.

What is Salagen?

Salagen has active ingredients of pilocarpine hydrochloride. It is often used in sjogren syndrome. eHealthMe is studying from 1,966 Salagen users. Check the latest studies of Salagen.

What is Convulsion?

Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body) is found to be associated with 1,854 drugs and 2,856 conditions by eHealthMe. Check the latest studies of Convulsion.

On Jul, 20, 2026

1,907 people reported to have side effects when taking Salagen.
Among them, 15 people (0.79%) have Convulsion.

Among these 15 people:

What is the gender of people who have Convulsion when taking Salagen? *

female: 93.33 %
male: 6.67 %

What is the age of people who have Convulsion when taking Salagen? *

What are other drugs people take besides Salagen? *

What are other side effects people have besides Convulsion? *

Dyspnea (difficult or laboured breathing): 10 people, 66.67%
White Blood Cell Count Decreased: 9 people, 60.00%
Joint Effusion (presence of extra fluid in joint covering): 9 people, 60.00%
Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 9 people, 60.00%
Indigestion: 9 people, 60.00%
Infection: 9 people, 60.00%
Insomnia (sleeplessness): 9 people, 60.00%
Itching: 9 people, 60.00%
Metabolic Disorder (an abnormal function and pattern of body fat. insulin resistance refers to the diminished ability of cells to respond to the action of insulin in promoting the transport of the sugar glucose, from blood into muscles and other tissues): 9 people, 60.00%
Hypoaesthesia (reduced sense of touch or sensation): 9 people, 60.00%

What are the existing conditions these people have? *

Breast Cancer: 9 people, 60.00%
Complex Regional Pain Syndrome (long lasting pain condition most often affecting one of the limbs (arms, legs, hands, or feet)): 2 people, 13.33%
Thyroid Diseases: 1 person, 6.67%
Sleep Disorder: 1 person, 6.67%
Pain: 1 person, 6.67%
Multiple Myeloma (cancer of the plasma cells): 1 person, 6.67%
Ill-Defined Disorder: 1 person, 6.67%
Depression: 1 person, 6.67%
Colon Cancer Metastatic (cancer of colon spreads to other part of body): 1 person, 6.67%
Breakthrough Pain: 1 person, 6.67%

* Approximation only. Some reports may have incomplete information.

Do you take Salagen and have Convulsion?

- Check whether Convulsion is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Salagen:

Salagen (1,966 reports)

Convulsion treatments and more:

Convulsion (99,535 reports)

Browse all side effects of Salagen:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Convulsion:

Convulsion (1,855 drugs)

Browse all the conditions that are associated with Convulsion:

Convulsion (2,856 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pilocarpine hydrochloride (the active ingredients of Salagen) and Salagen (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.